Evidence map›Paper›PMID 35121957›Full record

ArticleNature cancer2020

Publisher Correction: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1.

Rodrigo Romero, Francisco J Sánchez-Rivera, Peter M K Westcott, Kim L Mercer, Arjun Bhutkar, Alexander Muir, Tania J González Robles, Swanny Lamboy Rodríguez, Laura Z Liao, Sheng Rong Ng and 9 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 1 country.

Rodrigo Romero *Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-9388-8306
Francisco J Sánchez-Rivera *Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-8466-8563
Peter M K WestcottKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Kim L MercerKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Arjun BhutkarKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Alexander MuirKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Tania J González RoblesKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Swanny Lamboy RodríguezMassachusetts Institute of Technology Department of Biology, Cambridge, MA, USA.
Laura Z LiaoMassachusetts Institute of Technology Department of Biology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-1277-0956
Sheng Rong NgKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1655-2443
Leanne LiKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Caterina I ColónKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Santiago NaranjoKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Mary Clare BeytaghMassachusetts Institute of Technology Department of Biology, Cambridge, MA, USA.
Caroline A LewisWhitehead Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1787-5084
Peggy P HsuKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.
Roderick T BronsonTufts University, Boston, MA, USA.
Matthew G Vander HeidenKoch Institute for Integrative Cancer Research, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6702-4192
Tyler JacksKoch Institute for Integrative Cancer Research, Cambridge, MA, USA. tjacks@mit.edu.ORCID http://orcid.org/0000-0001-5785-8911
Allen Institute · USMassachusetts Institute of Technology · USHoward Hughes Medical Institute · USDana-Farber Cancer Institute · USMassachusetts General Hospital · USMemorial Sloan Kettering Cancer Center · USTufts University · USUniversity of Chicago · USWhitehead Institute for Biomedical Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35121957
OpenAlexW3080506150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.